ProCE Banner Activity

Current and Emerging Therapeutic Advances in Follicular Lymphoma


Downloadable slideset from an interactive text module on new and emerging immunotherapeutic approaches for the treatment of patients with relapsed/refractory follicular lymphoma

Released: February 23, 2023

Expiration: February 22, 2024

Begin Activity



John M. Burke

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

Jean Louise Koff

Jean Louise Koff, MD, MSc

Assistant Professor
Department of Hematology/Oncology
Winship Cancer Institute
Emory University
Atlanta, Georgia

Provided by

ProCE Banner


Bristol Myers Squibb

Genentech, a member of the Roche Group


John M. Burke, MD: consultant/advisor/speaker: AbbVie, Adaptive Biotechnologies, AstraZeneca, BeiGene, Bristol Myers Squibb, Epizyme, Kura, Kymera, MorphoSys, Novartis, Nurix, Roche/Genentech, Seattle Genetics, TG Therapeutics, Verastem, X4 Pharmaceuticals; researcher: MorphoSys; speaker's bureau: BeiGene, Seattle Genetics.

Jean Louise Koff, MD, MSc: consultant: Janssen/Pharmacyclics, Gamida Cell, MorphoSys, TG Therapeutics; researcher: Atara, Celgene, Janssen/Pharmacyclics, Oncternal, Viracta.